Innovational combinational therapies utilizing tumor-targeted oncolytic and adoptive T-cell therapy for lung cancer and mesothelioma
therapies ? a) oncolytic viral therapy, geneticallyengineered replicative-competent attenuated viruses that can selectively infect, replicate, lyse cancer cells sparing normal tissue, and b) Adoptive T-cell therapy…

